News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Elad Sharon: Another win for patients with ALL
Photo from Elad Sharon/X
Jul 25, 2024, 21:25

Elad Sharon: Another win for patients with ALL

Elad Sharon, Clinical and Translational Director of Dana-Farber Cancer Institute, shared on X:

“Another win for NCI, NCI CTEP Clinical Research, ECOG-ACRIN Cancer Research Group, but especially for patients with ALL! Amazing results with Amgen’s blinatumomab and for immunotherapy! Already approved by FDA Oncology...”

Elad Sharon: Another win for patients with ALL

Source: Elad Sharon/X

ALL Amgen blinatumomab cancer ECOG-ACRIN Cancer Research Group Elad Sharon FDA Oncology immunotherapy NCI NCI CTEP Clinical Research OncoDaily Oncology
Special Coverage
Insight
Oct 26, 2024, 18:39
Groundbreaking EMBER-4 Clinical Trial for Early Breast Cancer
Blog
Oct 26, 2024, 18:34
Zainab Shinkafi-Bagudu: Honored to be a panelist in The White House on the invitation of Biden Cancer moon shot
Blog
Oct 26, 2024, 18:30
MD Anderson's Boot Walk to End Cancer on Nov 2
Insight
Oct 26, 2024, 18:28
SAGA Trial Achieves Full Recruitment: A Milestone in Cancer Research
Blog
Oct 26, 2024, 18:22
Naveen Pemmaraju: Honored to speak and moderate two key sessions at the 16th International MPN Congress
Insight
Oct 26, 2024, 18:16
Key Insights from APCLC webinar - Lung Cancer Policy Network
Blog
Oct 26, 2024, 18:14
Abstract submission or the AACR IO Conference on Discovery and Innovation in Cancer Immunology
Blog
Oct 26, 2024, 18:14
BeiGene's BTK Inhibitor was successfully launched in Ethiopia for CLL patients at Black Lion Hospital
Blog
Oct 26, 2024, 18:07
CPOEM Foundation's Webinar on Molecular Understanding and Treatment Landscape of Gliomas
Insight
Oct 26, 2024, 18:03
Predicting treatment efficacy among cancer patients via ‘digital twins’
Blog
Oct 26, 2024, 17:39
Christian Rolfo: Putalyo Calvo on overcoming PD-1/PD-L1 immunotherapy limitations
Blog
Oct 26, 2024, 17:36
Highlights from the 2024 Childhood Cancer International Annual International Conference in Honolulu